Search research articles
Contact Us
Filters
Showing results (331-340 of 348) with videos related to
Page
of 35
Sort By:
Nature Communications
|
May 15, 2026
Naïve CD4<sup>+</sup> T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy
Michael Schneider, Luca Paruzzo, Federico Stella, et al.
Cancer Discovery
|
July 29, 2022
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer
Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, et al.
The New England Journal of Medicine
|
May 7, 2025
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
Jakub Svoboda, Daniel J Landsburg, James Gerson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 26, 2019
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Tania Jain, Merav Bar, Ankit J Kansagra, et al.
Nature Medicine
|
January 24, 2024
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
Guido Ghilardi, Joseph A Fraietta, James N Gerson, et al.
Plos One
|
September 3, 2011
Is chytridiomycosis an emerging infectious disease in Asia?
Andrea Swei, Jodi J L Rowley, Dennis Rödder, et al.
Blood Advances
|
April 9, 2025
Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter Study
Nikhil Yegya-Raman, John P Plastaras, Christopher M Wright, et al.
Blood Advances
|
June 23, 2022
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
Meghan C Thompson, Rosemary A Harrup, Catherine C Coombs, et al.
Blood Advances
|
August 5, 2025
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis
Zachary D Epstein-Peterson, Anath Christopher Lionel, Ashlee Joseph, et al.
The Journal of Infectious Diseases
|
July 25, 2024
Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia
Elise A Chong, Kingsley Gideon Kumashie, Emeline R Chong, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 348) with videos related to
Sort By:
Page
of 35
Nature Communications
|
May 15, 2026
Naïve CD4<sup>+</sup> T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy
Michael Schneider, Luca Paruzzo, Federico Stella, et al.
Cancer Discovery
|
July 29, 2022
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer
Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, et al.
The New England Journal of Medicine
|
May 7, 2025
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
Jakub Svoboda, Daniel J Landsburg, James Gerson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 26, 2019
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
Tania Jain, Merav Bar, Ankit J Kansagra, et al.
Nature Medicine
|
January 24, 2024
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
Guido Ghilardi, Joseph A Fraietta, James N Gerson, et al.
Plos One
|
September 3, 2011
Is chytridiomycosis an emerging infectious disease in Asia?
Andrea Swei, Jodi J L Rowley, Dennis Rödder, et al.
Blood Advances
|
April 9, 2025
Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter Study
Nikhil Yegya-Raman, John P Plastaras, Christopher M Wright, et al.
Blood Advances
|
June 23, 2022
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
Meghan C Thompson, Rosemary A Harrup, Catherine C Coombs, et al.
Blood Advances
|
August 5, 2025
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis
Zachary D Epstein-Peterson, Anath Christopher Lionel, Ashlee Joseph, et al.
The Journal of Infectious Diseases
|
July 25, 2024
Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia
Elise A Chong, Kingsley Gideon Kumashie, Emeline R Chong, et al.
Page
of 35